11.35
2.07%
0.23
After Hours:
11.35
Invizyne Technologies Inc stock is traded at $11.35, with a volume of 36,344.
It is up +2.07% in the last 24 hours and up +0.00% over the past month.
Invizyne Technologies Inc is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought-after chemicals. It believes that its biomanufacturing platform, known as SimplePath, will be a significant alternative to the current methods of chemical compound production, which are generally chemical synthesis, natural extraction, and synthetic biology. its objective with SimplePath is to enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform consists of a series of modular cascading enzyme-based biomanufacturing systems that leverage natural processes to perform complex chemical conversions.
See More
Previous Close:
$11.12
Open:
$11.33
24h Volume:
36,344
Relative Volume:
35.52
Market Cap:
$92.25M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
Invizyne Technologies Inc Stock (IZTC) Company Profile
Name
Invizyne Technologies Inc
Sector
Industry
Phone
-
Address
-
Compare IZTC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
IZTC | 11.35 | 92.25M | 0 | 0 | 0 | 0.00 |
LIN | 448.57 | 212.87B | 33.03B | 6.38B | 4.94B | 12.11 |
SHW | 375.35 | 95.64B | 23.05B | 2.56B | 2.05B | 9.34 |
APD | 327.89 | 72.30B | 12.10B | 3.83B | -3.15B | 9.83 |
ECL | 245.97 | 69.76B | 15.67B | 2.04B | 2.00B | 4.31 |
DD | 81.89 | 34.23B | 12.19B | 799.00M | 1.24B | 9.66 |
Invizyne Technologies Inc Stock (IZTC) Latest News
Opening Day: Invizyne Technologies jumps after IPO - MSN
Invizyne Technologies (IZTC) Stock Chart and Price History 2024 - MarketBeat
Invizyne's Nasdaq IPO Marks New Era of Biomanufacturing - Quantisnow
Invizyne Technologies Opens At $11.10, IPO Priced At $8 By Investing.com - Investing.com Canada
Invizyne Technologies stock climbs 13% following $15M IPO - MSN
Invizyne Technologies Begins Trading on NASDAQ - GlobeNewswire
Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024 - The Bakersfield Californian
Invizyne Technologies prices $15M U.S. IPO (Pending:IZTC.) - Seeking Alpha
Invizyne Technologies Launches $15M IPO, Sets Nasdaq Debut Under 'IZTC' Symbol | MDBH Stock News - StockTitan
TSX Health Care Capped Index (TTHC) QuotePress Release - The Globe and Mail
ULSD NY Harbor (HON24) Quote - The Globe and Mail
Invizyne Technologies Cuts IPO Size - MarketWatch
Biomanufacturing company Invizyne Technologies cuts share offering by 13% and adds rights ahead of $15 million IPO - Renaissance Capital
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq - GlobeNewswire
IZTC IPO NewsBiomanufacturing company Invizyne Technologies files and sets terms for a $17 million IPO - Renaissance Capital
Michael Burns Joins Invizyne as Executive Vice President of Energy Transition - GlobeNewswire
Invizyne Awarded Additional $3.77 Million Grant from U.S. Department of Energy - GlobeNewswire
Invizyne Technologies Inc Stock (IZTC) Financials Data
There is no financial data for Invizyne Technologies Inc (IZTC). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):